Abstract
Arg72Pro SNP of p53 has been associated with many types of cancer as well as with survival and longevity. We evaluated the Arg72Pro SNP frequencies of a Brazilian birth cohort and their association with current, demographic and birth epidemiological parameters available. In 1982, all hospital births of Pelotas, southern Brazil, were identified and studied prospectively. In 2004–5, blood samples were collected and DNA extracted. PCR-RFLP was used to genotype the Arg72Pro SNP in 3794 individual samples of the Brazil birth cohort and DNA sequencing was performed to confirm the genotypes. The genotype distribution, which was in Hardy–Weinberg equilibrium, showed a predominance of the arginine amino acid with a frequency of 46.9% Arg/Arg, 42.2% Arg/Pro and 10.9% Pro/Pro. The allele frequency was 0.68 of Arginine and 0.32 of Proline. The Arg72Pro SNP genotype and allelic frequency were related to skin colour where proline amino acid was observed more among black subjects, while arginine amino acid was observed more among white subjects. The individuals without family history of cancer and those with low birth weight were associated with arginine amino acid. The Arg72Pro SNP was strongly associated with important epidemiological variables confirming that genetic profiles on cohort studies can improve our understanding of the susceptibility of diseases and its risk factors.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
The molecular genetic technology allow the characterization of the most abundant genetic variation in the human genome, the single nucleotide polymorphisms (SNPs). Studies relating SNPs with human disease can help to identify precise molecular markers that can be applied for diagnostic and prognostic purposes and, possibly, novel therapeutic targets (Havill and Dyer 2005; Suh and Vijg 2005).
The polymorphism on 72 codon (Arg72Pro) (dbSNP ID: rs1042522) of TP53 gene is an important and most studied SNP that may be associated with cancer risk (De Moura Gallo et al. 2005; Olivier et al. 2010). Codon 72 belongs to the exon 4 and has both the sequence CCC, which encodes proline (Pro), a small and non-polar amino acid residue, or CGC, which encodes arginine (Arg), a large and polar amino acid residue (Wang et al. 1999; Whibley et al. 2009). Both variants had been considered wild type and result in a non-conservative change (Thomas et al. 1999; Pietsch et al. 2006). It has been reported that arginine and proline amino acids of Arg72Pro SNP are related to the occurrence of different types of cancer (Donehower 2005; Pietsch et al. 2006). The Proline variant would increased the risk for thyroid (Granja et al. 2004), gastric (Yi and Lee 2006), bladder (Pandith et al. 2010) and cervical cancer (Ye et al. 2010), whereas others studies have reported that arginine increased risk for others cancer types including breast (Kalemi et al. 2005) and colon and rectum cancer (Perez et al. 2006).
Only a few authors have studied the distribution of Arg72Pro SNP in the general population. Interestingly, a study reported the latitude dependence of arginine amino acid on Arg72Pro SNP and a tight association with cold winter temperature (Shi et al. 2009). A recent study from 52 populations worldwide found that proline amino acid was more prevalent among African and arginine among European population (Sucheston et al. 2011). An Indian study investigated the status of Arg72Pro SNP in different ethnic groups of North India. One of the groups studied (Ladakhi population), which was geographically isolated from the others groups and had oriental descent, had a frequency of Arg/Arg significantly different from all the others groups (which presented higher proline amino acid genotypes). The authors suggest that these are related to effects of racial differences and geographical isolation (Chosdol et al. 2002). A European study of a Danish cohort found higher frequencies of genotypes carrying arginine amino acid (Arg/Arg and Arg/Pro). This study also reported an important association of this SNP and increased survival after diagnosed of cancer or other life-threatening diseases as well as longevity. Moreover, the authors suggest that this SNP is an important gain-of-function genetic variant affecting the entire person (Orsted et al. 2007). By describing the genotypic and allelic distribution of the TP53, this study allows the identification of groups more susceptible to the development of chronic diseases. The present study evaluated the Arg72Pro SNP frequency of the TP53 gene in the 1982 birth cohort of Pelotas (Brazil) and its association with epidemiological parameters such as current, demographic and birth variables of this cohort.
2 Materials and methods
2.1 Study population
Pelotas is a southern Brazilian city, with a population of 350000 habitants. In 1982, all the city’s hospitals were visited on a daily basis and the hospital births identified. The 5914 live births (representing over 99% of all deliveries) whose mothers lived in the urban area of the city were examined and their mothers interviewed. The cohort has been followed up for several times and the study methodology has been previously described (Victora and Barros 2006; Barros et al. 2008). From October 2004 to August 2005, all households located in urban area of the city were visited in search of subjects belonging to the cohort. For those who had not been located and were not known to have died, the last known address and existing databases (including universities, secondary schools and telephone directories) were used for another attempt. Subjects answered a questionnaire on sociodemographic, health and behavioural variables and were invited to visit the research laboratory and give a blood sample (Victora and Barros 2006; Barros et al. 2008; Nazmi et al. 2008, 2009). The DNA was extracted as previously described (Miller et al. 1988), diluted on 3 aliquots and stored at −112°F (−80°C). These DNA samples present satisfactory quality and quantity for genetic studies. This study was approved by the Research Ethics Committee of the Federal University of Pelotas.
2.2 Genotyping
Arg72Pro SNP of TP53 gene was genotyped by PCR-RFLP using primers previously described (Lin et al. 2008). For the PCR reaction 5 ρmol of each primer, 10 ng of genomic DNA, 6 μl of GoTaq® qPCR Master Mix (Promega, USA) and H2O DNAse/RNAse free for a total reaction volume of 12 μl were used. The reaction was performed by the following conditions: 94°C for 5 min; 35 cycles of 94°C for 1 min, 57°C for 1 min and 72°C for 1 min; and 72°C for 5 min. The amplified PCR product of 199 bp was genotyping using 2 units of restriction enzyme BstUI (New England Biolabs, MA) and incubating at 60°C for 3 h. DNA fragments were electrophoresed through a 2.5% agarose gel and stained with GelRedTM (Biotium Inc., CA). The Pro72Pro genotype had one fragment with 199 bp, the heterozygous genotypes presents 3 bands with 199, 113 and 86 bp and the Arg72Arg formed 113 and 86 bp. All the assays were conducted blinded.
2.3 Sequencing
The Arg72Pro genotypes were confirmed by sequencing using both primers previously described (Lin et al. 2008). Before the sequencing step, PCR products were purified by the use of GFX PCR DNA and Gel Band purification kit according to manufacturer’s instructions (GE Healthcare, USA). The sequencing was performed in a MegaBACE 1000 DNA sequencer (GE Healthcare, USA) by the use of the Dynamic ET-terminator technology. Chromatograms were assembled and analysed using ContigExpress® module of Vector NTI 10.0 suite (Invitrogen, USA).
2.4 Statistical analyses
The chi-square (χ 2) test was used to evaluate the association between the Arg72Pro genotypes and the current and gestational variables of 1982 cohort: demographic, socioeconomic, anthropometric, physical activity, family history of cancer and related to pregnancy and birth. The skin colour variable was assessed by self-report from the individuals of 1982 birth cohort and classified as white, black or others which included mulatto, yellow, indigenous and dark. Socioeconomic status was defined following the Brazil Economic Classification Criterion, which considers points to the household characteristics, the level of education of household head and the purchasing power of individuals. A class, which is the highest, has 35 to 46 points; B class has 23 to 34 points; C class has 14 to 22; D class has 8 to 13 and E class, which is the lowest, has 0 to 7 points. The sedentary variables were defined on the 2004–2005 follow-up of the 1982 birth cohort, using the International Physical Activity Questionnaire (IPAQ) to investigate the physical activities. Those with weekly physical activity below 150 min were considered as sedentary. The variable Small for Gestational Age (SGA) follows the definition: children whose birth weight for gestational age and sex were below the 10th percentile in the reference population of Williams were considered as small for their gestational age. The Hardy–Weinberg equilibrium was also evaluated. Poisson regression was used in the multivariate analysis with the aim to eliminate the confounding factor of skin colour on all the variables. All data analyses were performed using Stata 11.0.
3 Results
In the 2004–5 follow-up visits, 4297 subjects were interviewed. In addition to the 282 known to have died, they represented a follow-up rate of 77.4%. Among the 4297 interviewed, 3914 went to the laboratory to donate a blood sample. The Arg72Pro SNP of TP53 gene was genotyped in 3794 individuals.
The genotype distributions among the 1982 birth cohort were in Hardy–Weinberg equilibrium. The table 1 shows the frequency distributions of genotypes and alleles of Arg72Pro on the 1982 birth cohort and among the skin colour variable. The genotypes showed a frequency of 46.9% Arg/Arg, 42.2% Arg/Pro and only 10.9% Pro/Pro, while the allele frequency was 0.68 of arginine and 0.32 of proline. On skin colour, black subjects were less likely to carry an arginine amino acid, whereas the proportion of homozygote for proline was higher among these subjects.
The table 2 shows the frequency distribution of 1982 birth cohort variables among skin colour. The schooling and socioeconomic status were associated with skin colour. The white group had a higher frequency of subjects with 12 or more years of schooling than the black or other groups (P-value of 0.000). In the same way, the white group had a higher frequency of subjects on higher socioeconomic classes than the black or other groups (P-value of 0.000). Height, body mass index (BMI) and total sedentary were also associated with skin colour (P-value of 0.019, 0.008 and 0.000, respectively). The family history of cancer showed no associations with skin colour. Among variables related to pregnancy and birth, maternal smoking in pregnancy was associated with skin colour (P-value of 0.000), and on birth weight variable, higher frequencies of the lower weight group was found in black subjects (P-value of 0.011).
The analysis of Arg72Pro SNP of TP53 gene on the variables of 1982 birth cohort controlled for skin colour are presented on table 3. The main findings of the influence of this SNP on characteristics of 1982 cohort were related to history family of cancer and birth weight.
In the cohort, 6.99% had a family history of cancer. It was found an association between the Arginine allele and the individuals without family history of cancer with a risk of 0.94 (95% confidence interval: 0.90–0.99) and P-value of 0.028. The group of individuals without family history of cancer had 89.4% of Arginine carriers. Also, on birth weight was found an association between subjects whose birth weight was lower than 2500 g and Arginine allele with a risk of 1.06 (95% confidence interval: 1.03–1.10) and a P-value of 0.000. The group of lower birth weight had 93.2% of Arginine carriers. Still, the genotypes analysis of this variable showed a risk of 0.95 (95% confidence interval: 0.91–1.00) and P-value of 0.052.
4 Discussion
The Arg72Pro is the most extensively studied SNP of TP53 gene and have been associated with different types of cancers (Pietsch et al. 2006), increased survival after diagnosed of cancer or other life-threatening diseases and longevity (Orsted et al. 2007), as well with human reproductive parameters (Hu 2009). In 1982 birth cohort, 6.99% of population has a first-degree family member with history of cancer, with the most prevalent cancers types being: breast, prostate, lung, stomach, cervical, brain, pharynx and leukemia. We found an association between the individuals without family history of cancer and the Arginine allele with about 89% of these individuals carrying the arginine amino acid. Dumont et al. (2003) found that Arginine variant of Arg72Pro SNP is more able at inducing apoptosis than Proline. Recently studies reported that Arginine allele carriers are associated with decreasing of esophageal cancer (Jiang et al. 2011) as well as bladder cancer risk (Jiang et al. 2010) being this a protective factor in both cases.
Concerning the skin colour, our study reveals a clear association. Although the frequency of arginine amino acid was higher among white individuals, the Proline allele, on the contrary, was prevalent among individuals with black skin colour. Studies that have been genotyping the Arg72Pro SNP among populations of diverse countries have found different frequencies of this polymorphism, showing that this SNP could be dependent of the characteristic of each population. A study discussed the genetic adaptations occurred in human life, since our ancestors left the Africa about 100000 years ago, in response to environmental adaptations. The authors affirm that when humans left the African continent and started to explore northward to high-latitude regions, the arginine amino acid of Arg72Pro SNP was selected by winter temperature and enriched in the populations living in the north (Shi and Su 2011). Recently, a study that genotyped the Arg72Pro SNP among 971 individuals from 52 populations worldwide noticed a difference in allele frequencies among different populations and also found the ancestral C allele, encoding the Pro variant, predominating among Africans, but the G variant, encoding the Arg variant, more common among Europeans (Sucheston et al. 2011). A study from north India identified higher frequency of Arg/Arg genotypes on Ladakhi population, which is geographically isolated from the other groups genotyped and have Oriental descent. On the other hand, the other Indian groups presented higher frequencies of genotypes with proline amino acid (Arg/Pro and Pro/Pro). The authors concluded that the difference in prevalence of these amino acids could be because of racial differences and geographic isolation (Chosdol et al. 2002). An interestingly European study of a Danish cohort reported higher frequencies of Arginine-carrying genotypes (Arg/Arg and Arg/Pro). This study also reported that the Arg/Pro and Pro/Pro carriers have reduced mortality, which could result from a generally decreased aging process. They concluded that this SNP leads to increased longevity and survival after diagnosis of cancer or other life-threatening diseases being this SNP an important variant affecting various human developments (Orsted et al. 2007). Other studies have also associated longevity and the Arg72Pro SNP. A study from Italy and Sardinia genotyped young and centenarians people for Arg72Pro SNP and observed that proline amino acid was slightly increased in centenarians when compared that in young people (Bonafe et al. 1999). Another study also suggests the role of this SNP on longevity, affirming that despite having an increased cancer incidence, individuals carrying Pro/Pro genotype exhibited enhanced survival compared to Arg/Arg and Arg/Pro individuals (Donehower 2005). All studies confirm the importance of epidemiological studies on a molecular level.
Another important feature relating to the p53 protein and skin colour is the melanogenesis. Studies show that p53 initiates melanogenesis activation via POMC gene (Pro-opiomelanocortin) in keratinocytes in response to UV radiation (Ultraviolet). The POMC gene product is cleaved generating α-MSH (α-melanocyte stimulating hormone), which activates the receptor MC1R (melanocortin receptor 1) in melanocytes (Cui et al. 2007). Another study indicates that the Proline allele might provide a protective effect by potently stimulating POMC expression in response to UV radiation (Miller and Tsao 2010). A recent study also demonstrated a different gene expression related to each etnia (Sharma et al. 2011).
Regarding the gestational variables, we found an association between birth weight and Arginine allele, wherein the low birth weight group had the higher frequency of Arginine allele, about 93%. Also, the genotypes showed a P-value of 0.052 in the same group. The authors affirm that the p53 protein has a role on development, on which the right balance of p53 levels is essential, and in contrast, a malfunction of this regulation may guide to embryonic lethality or malformations (Choi and Donehower 1999; Danilova et al. 2008). Also, birth weight has been associated to obesity in adulthood, which can have consequences to health problems (Leong et al 2003). So, considering the role of p53 in embryonic development and the value of birth weight to human development, analysis of a SNP in p53 gene and its role in birth weight is of importance. A very recent work has studied a cohort of pregnant women and newborns of places with different levels of air pollution. Besides the air pollutions, they also studied polymorphisms in genes related to DNA repair, oxidative stress, xenobiotic metabolism and immune functions including the Arg72Pro SNP, on which they had not found any association (Rossner et al. 2010).
In summary, we observed important associations between the Arg72Pro SNP and epidemiological variables of the 1982 birth cohort. Mainly, the skin colour was associated with genotypes and both alleles of Arg72Pro SNP and the individuals without family history of cancer were associated with arginine amino acid of the same SNP. In addition, low birth weight was related to arginine amino acid of Arg72Pro SNP.
Some of the statistically significant association could be due to type error I, introduced by multiple testing. Such error could be an explanation for the observed association between genotype and family history of cancer and birth weight. If we had corrected the P-value of these associations for multiple testing, the null hypothesis would not be rejected. We preferred not to include the correction for multiple testing for the reason that it could increase the finding of a spurious association. On the other hand, for skin colour, the association remained statistically significant even after adjustment for multiple comparisons. Furthermore, a similar association has been reported in other studies, reinforcing therefore the likelihood of the existence between genotype and skin colour.
The importance of gene–environment interactions has been emphasized in order to clarify the susceptibility to many common complex diseases (Bookman et al. 2011). Thus, data of genetic variations into epidemiologic research allows characterizing the genetic profiles of a population in association with strong epidemiological parameters that can contribute to identifications of molecular markers and the susceptibility of diseases and conditions that had been widely studied in epidemiology.
References
Barros FC, Victora CG, Horta BL and Gigante DP 2008 Methodology of the Pelotas birth cohort study from 1982 to 2004–5, Southern Brazil. Rev. Saude Publica 42 Suppl 2 7–15
Bonafe M, Olivieri F, Mari D, Baggio G, Mattace R, Berardelli M, Sansoni P, De BG, et al. 1999 P53 codon 72 polymorphism and longevity: additional data on centenarians from continental Italy and Sardinia. Am. J. Hum. Genet. 65 1782–1785
Bookman EB, McAllister K, Gillanders E, Wanke K, Balshaw D, Rutter J, Reedy J, Shaughnessy D, et al. 2011 Gene-environment interplay in common complex diseases: forging an integrative model-recommendations from an NIH workshop. Genet. Epidemiol. 35 217–225
Choi J and Donehower LA 1999 p53 in embryonic development: maintaining a fine balance. Cell Mol. Life Sci. 55 38–47
Chosdol K, Ahuja A, Rathore A, Misra A, Mir SH, Chattopadhyay P and Sinha S 2002 Study of p53 codon 72 polymorphism in various ethnic groups of North India. Curr. Sci. 82 1253–1255
Cui R, Widlund HR, Feige E, Lin JY, Wilensky DL, Igras VE, D’Orazio J, Fung CY, Schanbacher CF, Granter SR and Fisher DE 2007 Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128 853–864
Danilova N, Sakamoto KM and Lin S 2008 Role of p53 family in birth defects: lessons from zebrafish. Birth Defects Res. C. Embryo. Today 84 215–227
De Moura Gallo CV, Azevedo E Silva Mendonca, de Moraes E, Olivier M and Hainaut P 2005 TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives. Mutat. Res. 589 192–207
Donehower LA 2005 p53: guardian AND suppressor of longevity? Exp. Gerontol. 40 7–9
Dumont P, Leu JI, Della Pietra AC, George DL and Murphy M 2003 The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33 357–365
Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV and Ward LS 2004 Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett. 210 151–157
Havill LM and Dyer TD 2005 Association mapping: methodologies, strategies and issues. Genet. Epidemiol. 29 Suppl 1 S77-S85
Hu W 2009 The role of p53 gene family in reproduction. Cold Spring Harb. Perspect. Biol. 1 a001073
Jiang DK, Ren WH, Yao L, Wang WZ, Peng B and Yu L 2010 Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk. Urology 76 765–767
Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM and Yu L 2011 TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. World J. Gastroenterol. 17 1227–1233
Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT and Kotsis A 2005 The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett. 222 57–65
Leong NM, Mignone LI, Newcomb PA, Titus-Ernstoff L, Baron JA, Trentham-Dietz A, Stampfer MJ, Willett WC and Egan KM 2003 Early life risk factors in cancer: the relation of birth weight to adult obesity. Int. J. Cancer 103 789–791
Lin YC, Huang HI, Wang LH, Tsai CC, Lung O, Dai CY, Yu ML, Ho CK and Chen CH 2008 Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Oral Oncol. 44 798–804
Miller AJ and Tsao H 2010 New insights into pigmentary pathways and skin cancer. Br. J. Dermatol. 162 22–28
Miller SA, Dykes DD and Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 1215
Nazmi A, Gonzalez DC, Oliveira IO, Horta BL, Gigante DP and Victora CG 2009 Life course weight gain and C-reactive protein levels in young adults: findings from a Brazilian birth cohort. Am. J. Hum. Biol. 21 192–199
Nazmi A, Oliveira IO and Victora CG 2008 Correlates of C-reactive protein levels in young adults: a population-based cohort study of 3827 subjects in Brazil. Braz. J. Med. Biol. Res. 41 357–367
Olivier M, Hollstein M and Hainaut P 2010 TP53 Mutations in Human Cancers: Origins, Consequences and Clinical Use. Cold Spring Harb. Perspect. Biol. 2 a001008
Orsted DD, Bojesen SE, Tybjaerg-Hansen A and Nordestgaard BG 2007 Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival and risk of cancer in the general population. J. Exp. Med. 204 1295–1301
Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S and Siddiqi M 2010 Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet. Cytogenet. 203 263–268
Perez LO, Abba MC, Dulout FN and Golijow CD 2006 Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J. Gastroenterol. 12 1426–1429
Pietsch EC, Humbey O and Murphy ME 2006 Polymorphisms in the p53 pathway. Oncogene 25 1602–1611
Rossner P Jr, Tabashidze N, Dostal M, Novakova Z, Chvatalova I, Spatova M and Sram RJ 2010 Genetic, biochemical and environmental factors associated with pregnancy outcomes in newborns from the Czech Republic. Environ Health Perspect. 119 265–271
Sharma S, Murphy A, Howrylak J, Himes B, Cho MH, Chu JH, Hunninghake GM, Fuhlbrigge A, et al. 2011 The impact of self-identified race on epidemiologic studies of gene expression. Genet. Epidemiol. 35 93–101
Shi H and Su B 2011 Molecular adaptation of modern human populations. Int. J. Evol. Biol. 2011 1–8
Shi H, Tan SJ, Zhong H, Hu W, Levine A, Xiao CJ, Peng Y, Qi XB, Shou WH, Ma RL, Li Y, Su B and Lu X 2009 Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am. J. Hum. Genet. 84 534–541
Sucheston L, Witonsky DB, Hastings D, Yildiz O, Clark VJ, Di RA and Onel K 2011 Natural selection and functional genetic variation in the p53 pathway. Hum. Mol. Genet. 20 1502–1508
Suh Y and Vijg J 2005 SNP discovery in associating genetic variation with human disease phenotypes. Mutat. Res. 573 41–53
Thomas M, Kalita A, Labrecque S, Pim D, Banks L and Matlashewski G 1999 Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell Biol. 19 1092–1100
Victora CG and Barros FC 2006 Cohort profile: the 1982 Pelotas (Brazil) birth cohort study. Int. J. Epidemiol. 35 237–242
Wang YC, Lee HS, Chen SK, Chang YY and Chen CY 1999 Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur. J. Cancer 35 226–230
Whibley C, Pharoah PD and Hollstein M 2009 p53 polymorphisms: cancer implications. Nat. Rev. Cancer 9 95–107
Ye F, Zhang J, Cheng Q, Shen J and Chen H 2010 p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population. Cancer Lett. 287 117–121
Yi SY and Lee WJ 2006 A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer. World J. Gastroenterol. 12 6536–653
Acknowledgements
This work was supported by the World Health Organization (Department of Child and Adolescent Health) and the Welcome Trusts initiative entitled Major Awards for Latin America on Health Consequences of Population Change. Earlier phases of the 1982 cohort study were funded by the International Development Research Center (Canada), the World Health Organization (Department of Child and Adolescent Health and Development, and Human Reproduction Programme), the Overseas Development Administration (United Kingdom), the United Nations Development Fund for Women, the National Program for Centers of Excellence (Brazil), the National Research Council (Brazil) and the Ministry of Health (Brazil). This work was also supported by Brazilian CNPq and FAPERGS. HST was supported by CAPES and FPH was supported by FAPERGS.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: Sarah H Elsea
[Thurow HS, Haack R, Hartwig FP, de Oliveira IO, Dellagostin OA, Gigante DP, Horta BL, Collares T and Seixas FK 2011 TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort. J. Biosci. 36 1–9] DOI
Rights and permissions
About this article
Cite this article
Thurow, H.S., Haack, R., Hartwig, F.P. et al. TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort. J Biosci 36, 823–831 (2011). https://doi.org/10.1007/s12038-011-9147-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-011-9147-5